Filter Results:
(150)
Show Results For
- All HBS Web (150)
- Faculty Publications (19)
Show Results For
- All HBS Web (150)
- Faculty Publications (19)
- 01 Sep 2008
- News
Mara Aspinall
presidential candidates have acknowledged the need for change, and that opens up an opportunity to shift from payment based on activity to payment based on quality and outcome mea-sures. One part of that will be improving the efficacy of... View Details
- 17 Feb 2016
- Blog Post
Through The Eyes of The Patient: A Recap of The 13th Annual Health Care Conference
David Torchiana, President and CEO of Partners HealthCare in Boston delivered the morning keynote address, and spoke about improvements in the quality of care over time, then looked forward in discussing what impact further improvement in... View Details
Keywords: Health Care
- 02 Feb 2021
- Blog Post
Finding My Focus in Health care Amidst a Global Pandemic
can redefine the Health care industry and sparked my interest in exploring how the public and private sectors can work together to improve patient outcomes. With the summer internship search heating up, I am excited to explore opportunities as an intern at the Food and... View Details
- 24 Jun 2016
- News
Reinventing Pharma
2004) began her career as a research scientist. Eventually expanding her responsibilities into business development led her to HBS, where she hoped to solidify her understanding of the intersection of science and business. Following graduation, she joined Novartis,... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
alluring qualities of a brand without committing to it. We propose that brand flirting is exciting and that when consumers flirt with a brand other than their typically preferred brand in the same product category, they can transfer this... View Details
Keywords: Sean Silverthorne
- 13 Oct 2016
- News
Adding Muscle to the Fight Against Disease
biotech companies—as a function of cost, time, and failure modes—tend to risk pivot on one program, one clinical trial, one outcome,” he observes. “Our company is the leader in mining muscle biology for drug discoveries that translate... View Details
Keywords: Deborah Blagg
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
healthcare is not high quality. Indeed, there is every possible quality problem you can imagine: incorrect diagnoses, drug errors, unnecessary complications, and failed treatments. Also, there are huge... View Details
- 01 Mar 2007
- News
HBS Alums Help Jailhouse Entrepreneurs Go Straight
Like it or not, a drug dealer, for example, already knows a lot about what it takes to run a successful business. Teaching them passion is not something we have to do; what we teach them is how to go legit.” At HBS, several students are... View Details
- 01 Sep 2006
- News
Redefining Health Care
high costs understandable. What Wennberg and others did was to show that U.S. health care also has severe quality problems. Indeed, there is every possible quality problem you can imagine: incorrect... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
general purpose (e.g., quality management) to highly market specific (e.g., knowing how to manufacture an airplane wing). To illustrate the potential of the framework to shed new light on traditional strategy questions, the article... View Details
Keywords: Sean Silverthorne
- 01 Dec 2002
- News
Alumni Honorees Urge Students to Emphasize Ethics
2002 Alumni Achievement Awards Raymond V. Gilmartin (MBA '68) Chairman, President, and CEO, Merck & Co. Since June 1994, when Gilmartin became its president and CEO, Merck has launched seventeen new drugs and increased revenues from $15... View Details
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
president, Moret created a new, reorganized student government and lobbied the faculty to place a greater emphasis on teaching quality in granting tenure. After graduating from LSU, Moret remained in Baton Rouge and worked as an... View Details
- 16 Oct 2013
- Op-Ed
Response to Readers: Combating Climate Change with Nuclear Power and Fracking
With more than 7,500 views and 180-plus tweets, I want to thank everyone for taking the time to read the original HBS Working Knowledge piece, The Case for Combating Climate Change with Nuclear Power and Fracking, and, in particular, for sharing your thoughts with one... View Details
- 04 Aug 2009
- First Look
First Look: August 4
Download the paper: http://www.hbs.edu/research/pdf/10-005.pdf The Effect of Labor on Profitability: The Role of Quality (revised) Author:Zeynep Ton Abstract Determining staffing levels is an important decision in retail operations. While... View Details
Keywords: Martha Lagace
- 27 Sep 2011
- First Look
First Look: September 27
resources furnished by its partners. Receptivity in turn portrays how organizational capabilities and the quality of ties to partners facilitate flows of network resources. We propose that the interplay of these three mechanisms... View Details
Keywords: Sean Silverthorne
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
HBS Professor Clayton Christensen sees disruptive innovation as a threat to everything from Microsoft to Japan—and even to a certain prominent business school. But through that disruption comes improved quality of life—and major... View Details
- 01 Sep 2004
- News
A Market-Based Prescription
curb cost increases while ensuring quality treatment. Those goals have not been reached, largely because patient and physician resistance to stringent gatekeeping has led to more relaxed controls and freedom to use out-of-network... View Details
- 25 May 2016
- Research & Ideas
How Consumers and Businesses are Reshaping Public Health
commercialization of important new drugs to the detriment of consumers. Interestingly, though, at public hearings, the AstraZeneca chief executive championed the interests of patients in opposing the proposed merger. Consumers worldwide... View Details
- 07 Aug 2006
- Research & Ideas
Whatever Happened to Caveat Emptor?
basic material needs to concerns about the safety and quality of these products. When products did fail—as happened dramatically in the late 1950s with the antinausea drug Thalidomide—such cases became the... View Details